Global Opioid Use Disorder Treatment Market Growth 2026-2032
The global Opioid Use Disorder Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Opioid Use Disorder Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Opioid Use Disorder Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Opioid Use Disorder Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Opioid Use Disorder Treatment players cover Trevena, Aphios, Kyowa kirin, Gamida-Cell, Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Opioid Use Disorder Treatment Industry Forecast? looks at past sales and reviews total world Opioid Use Disorder Treatment sales in 2025, providing a comprehensive analysis by region and market sector of projected Opioid Use Disorder Treatment sales for 2026 through 2032. With Opioid Use Disorder Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioid Use Disorder Treatment industry.
This Insight Report provides a comprehensive analysis of the global Opioid Use Disorder Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioid Use Disorder Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Opioid Use Disorder Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioid Use Disorder Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioid Use Disorder Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Use Disorder Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Opioid Use Disorder Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Opioid Use Disorder Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Opioid Use Disorder Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Opioid Use Disorder Treatment players cover Trevena, Aphios, Kyowa kirin, Gamida-Cell, Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Opioid Use Disorder Treatment Industry Forecast? looks at past sales and reviews total world Opioid Use Disorder Treatment sales in 2025, providing a comprehensive analysis by region and market sector of projected Opioid Use Disorder Treatment sales for 2026 through 2032. With Opioid Use Disorder Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioid Use Disorder Treatment industry.
This Insight Report provides a comprehensive analysis of the global Opioid Use Disorder Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioid Use Disorder Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Opioid Use Disorder Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioid Use Disorder Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioid Use Disorder Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Use Disorder Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Romiplostim
- Omidubicel
- Nalmefene
- Others
- Hospital
- Drug Stores
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Trevena
- Aphios
- Kyowa kirin
- Gamida-Cell
- Novartis
- Titan Pharmaceutical
- Hikma Pharmaceutical
- MediciNova
- Alkermes
- BioDelivery Sciences International
- What is the 10-year outlook for the global Opioid Use Disorder Treatment market?
- What factors are driving Opioid Use Disorder Treatment market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Opioid Use Disorder Treatment market opportunities vary by end market size?
- How does Opioid Use Disorder Treatment break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioid Use Disorder Treatment Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Opioid Use Disorder Treatment by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Opioid Use Disorder Treatment by Country/Region, 2021, 2025 & 2032
2.2 Opioid Use Disorder Treatment Segment by Type
2.2.1 Romiplostim
2.2.2 Omidubicel
2.2.3 Nalmefene
2.2.4 Others
2.2.5 Opioid Use Disorder Treatment Sales by Type
2.2.5.1 Global Opioid Use Disorder Treatment Sales Market Share by Type (2021-2026)
2.2.5.2 Global Opioid Use Disorder Treatment Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Opioid Use Disorder Treatment Sale Price by Type (2021-2026)
2.3 Opioid Use Disorder Treatment Segment by Application
2.3.1 Hospital
2.3.2 Drug Stores
2.3.3 Other
2.3.4 Opioid Use Disorder Treatment Sales by Application
2.3.4.1 Global Opioid Use Disorder Treatment Sale Market Share by Application (2021-2026)
2.3.4.2 Global Opioid Use Disorder Treatment Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Opioid Use Disorder Treatment Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Opioid Use Disorder Treatment Breakdown Data by Company
3.1.1 Global Opioid Use Disorder Treatment Annual Sales by Company (2021-2026)
3.1.2 Global Opioid Use Disorder Treatment Sales Market Share by Company (2021-2026)
3.2 Global Opioid Use Disorder Treatment Annual Revenue by Company (2021-2026)
3.2.1 Global Opioid Use Disorder Treatment Revenue by Company (2021-2026)
3.2.2 Global Opioid Use Disorder Treatment Revenue Market Share by Company (2021-2026)
3.3 Global Opioid Use Disorder Treatment Sale Price by Company
3.4 Key Manufacturers Opioid Use Disorder Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioid Use Disorder Treatment Product Location Distribution
3.4.2 Players Opioid Use Disorder Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OPIOID USE DISORDER TREATMENT BY GEOGRAPHIC REGION
4.1 World Historic Opioid Use Disorder Treatment Market Size by Geographic Region (2021-2026)
4.1.1 Global Opioid Use Disorder Treatment Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Opioid Use Disorder Treatment Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Opioid Use Disorder Treatment Market Size by Country/Region (2021-2026)
4.2.1 Global Opioid Use Disorder Treatment Annual Sales by Country/Region (2021-2026)
4.2.2 Global Opioid Use Disorder Treatment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Opioid Use Disorder Treatment Sales Growth
4.4 APAC Opioid Use Disorder Treatment Sales Growth
4.5 Europe Opioid Use Disorder Treatment Sales Growth
4.6 Middle East & Africa Opioid Use Disorder Treatment Sales Growth
5 AMERICAS
5.1 Americas Opioid Use Disorder Treatment Sales by Country
5.1.1 Americas Opioid Use Disorder Treatment Sales by Country (2021-2026)
5.1.2 Americas Opioid Use Disorder Treatment Revenue by Country (2021-2026)
5.2 Americas Opioid Use Disorder Treatment Sales by Type (2021-2026)
5.3 Americas Opioid Use Disorder Treatment Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid Use Disorder Treatment Sales by Region
6.1.1 APAC Opioid Use Disorder Treatment Sales by Region (2021-2026)
6.1.2 APAC Opioid Use Disorder Treatment Revenue by Region (2021-2026)
6.2 APAC Opioid Use Disorder Treatment Sales by Type (2021-2026)
6.3 APAC Opioid Use Disorder Treatment Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioid Use Disorder Treatment by Country
7.1.1 Europe Opioid Use Disorder Treatment Sales by Country (2021-2026)
7.1.2 Europe Opioid Use Disorder Treatment Revenue by Country (2021-2026)
7.2 Europe Opioid Use Disorder Treatment Sales by Type (2021-2026)
7.3 Europe Opioid Use Disorder Treatment Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioid Use Disorder Treatment by Country
8.1.1 Middle East & Africa Opioid Use Disorder Treatment Sales by Country (2021-2026)
8.1.2 Middle East & Africa Opioid Use Disorder Treatment Revenue by Country (2021-2026)
8.2 Middle East & Africa Opioid Use Disorder Treatment Sales by Type (2021-2026)
8.3 Middle East & Africa Opioid Use Disorder Treatment Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioid Use Disorder Treatment
10.3 Manufacturing Process Analysis of Opioid Use Disorder Treatment
10.4 Industry Chain Structure of Opioid Use Disorder Treatment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioid Use Disorder Treatment Distributors
11.3 Opioid Use Disorder Treatment Customer
12 WORLD FORECAST REVIEW FOR OPIOID USE DISORDER TREATMENT BY GEOGRAPHIC REGION
12.1 Global Opioid Use Disorder Treatment Market Size Forecast by Region
12.1.1 Global Opioid Use Disorder Treatment Forecast by Region (2027-2032)
12.1.2 Global Opioid Use Disorder Treatment Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Opioid Use Disorder Treatment Forecast by Type (2027-2032)
12.7 Global Opioid Use Disorder Treatment Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Trevena
13.1.1 Trevena Company Information
13.1.2 Trevena Opioid Use Disorder Treatment Product Portfolios and Specifications
13.1.3 Trevena Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Trevena Main Business Overview
13.1.5 Trevena Latest Developments
13.2 Aphios
13.2.1 Aphios Company Information
13.2.2 Aphios Opioid Use Disorder Treatment Product Portfolios and Specifications
13.2.3 Aphios Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Aphios Main Business Overview
13.2.5 Aphios Latest Developments
13.3 Kyowa kirin
13.3.1 Kyowa kirin Company Information
13.3.2 Kyowa kirin Opioid Use Disorder Treatment Product Portfolios and Specifications
13.3.3 Kyowa kirin Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Kyowa kirin Main Business Overview
13.3.5 Kyowa kirin Latest Developments
13.4 Gamida-Cell
13.4.1 Gamida-Cell Company Information
13.4.2 Gamida-Cell Opioid Use Disorder Treatment Product Portfolios and Specifications
13.4.3 Gamida-Cell Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Gamida-Cell Main Business Overview
13.4.5 Gamida-Cell Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Opioid Use Disorder Treatment Product Portfolios and Specifications
13.5.3 Novartis Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Titan Pharmaceutical
13.6.1 Titan Pharmaceutical Company Information
13.6.2 Titan Pharmaceutical Opioid Use Disorder Treatment Product Portfolios and Specifications
13.6.3 Titan Pharmaceutical Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Titan Pharmaceutical Main Business Overview
13.6.5 Titan Pharmaceutical Latest Developments
13.7 Hikma Pharmaceutical
13.7.1 Hikma Pharmaceutical Company Information
13.7.2 Hikma Pharmaceutical Opioid Use Disorder Treatment Product Portfolios and Specifications
13.7.3 Hikma Pharmaceutical Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Hikma Pharmaceutical Main Business Overview
13.7.5 Hikma Pharmaceutical Latest Developments
13.8 MediciNova
13.8.1 MediciNova Company Information
13.8.2 MediciNova Opioid Use Disorder Treatment Product Portfolios and Specifications
13.8.3 MediciNova Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 MediciNova Main Business Overview
13.8.5 MediciNova Latest Developments
13.9 Alkermes
13.9.1 Alkermes Company Information
13.9.2 Alkermes Opioid Use Disorder Treatment Product Portfolios and Specifications
13.9.3 Alkermes Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Alkermes Main Business Overview
13.9.5 Alkermes Latest Developments
13.10 BioDelivery Sciences International
13.10.1 BioDelivery Sciences International Company Information
13.10.2 BioDelivery Sciences International Opioid Use Disorder Treatment Product Portfolios and Specifications
13.10.3 BioDelivery Sciences International Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 BioDelivery Sciences International Main Business Overview
13.10.5 BioDelivery Sciences International Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioid Use Disorder Treatment Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Opioid Use Disorder Treatment by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Opioid Use Disorder Treatment by Country/Region, 2021, 2025 & 2032
2.2 Opioid Use Disorder Treatment Segment by Type
2.2.1 Romiplostim
2.2.2 Omidubicel
2.2.3 Nalmefene
2.2.4 Others
2.2.5 Opioid Use Disorder Treatment Sales by Type
2.2.5.1 Global Opioid Use Disorder Treatment Sales Market Share by Type (2021-2026)
2.2.5.2 Global Opioid Use Disorder Treatment Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Opioid Use Disorder Treatment Sale Price by Type (2021-2026)
2.3 Opioid Use Disorder Treatment Segment by Application
2.3.1 Hospital
2.3.2 Drug Stores
2.3.3 Other
2.3.4 Opioid Use Disorder Treatment Sales by Application
2.3.4.1 Global Opioid Use Disorder Treatment Sale Market Share by Application (2021-2026)
2.3.4.2 Global Opioid Use Disorder Treatment Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Opioid Use Disorder Treatment Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Opioid Use Disorder Treatment Breakdown Data by Company
3.1.1 Global Opioid Use Disorder Treatment Annual Sales by Company (2021-2026)
3.1.2 Global Opioid Use Disorder Treatment Sales Market Share by Company (2021-2026)
3.2 Global Opioid Use Disorder Treatment Annual Revenue by Company (2021-2026)
3.2.1 Global Opioid Use Disorder Treatment Revenue by Company (2021-2026)
3.2.2 Global Opioid Use Disorder Treatment Revenue Market Share by Company (2021-2026)
3.3 Global Opioid Use Disorder Treatment Sale Price by Company
3.4 Key Manufacturers Opioid Use Disorder Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioid Use Disorder Treatment Product Location Distribution
3.4.2 Players Opioid Use Disorder Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OPIOID USE DISORDER TREATMENT BY GEOGRAPHIC REGION
4.1 World Historic Opioid Use Disorder Treatment Market Size by Geographic Region (2021-2026)
4.1.1 Global Opioid Use Disorder Treatment Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Opioid Use Disorder Treatment Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Opioid Use Disorder Treatment Market Size by Country/Region (2021-2026)
4.2.1 Global Opioid Use Disorder Treatment Annual Sales by Country/Region (2021-2026)
4.2.2 Global Opioid Use Disorder Treatment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Opioid Use Disorder Treatment Sales Growth
4.4 APAC Opioid Use Disorder Treatment Sales Growth
4.5 Europe Opioid Use Disorder Treatment Sales Growth
4.6 Middle East & Africa Opioid Use Disorder Treatment Sales Growth
5 AMERICAS
5.1 Americas Opioid Use Disorder Treatment Sales by Country
5.1.1 Americas Opioid Use Disorder Treatment Sales by Country (2021-2026)
5.1.2 Americas Opioid Use Disorder Treatment Revenue by Country (2021-2026)
5.2 Americas Opioid Use Disorder Treatment Sales by Type (2021-2026)
5.3 Americas Opioid Use Disorder Treatment Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid Use Disorder Treatment Sales by Region
6.1.1 APAC Opioid Use Disorder Treatment Sales by Region (2021-2026)
6.1.2 APAC Opioid Use Disorder Treatment Revenue by Region (2021-2026)
6.2 APAC Opioid Use Disorder Treatment Sales by Type (2021-2026)
6.3 APAC Opioid Use Disorder Treatment Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioid Use Disorder Treatment by Country
7.1.1 Europe Opioid Use Disorder Treatment Sales by Country (2021-2026)
7.1.2 Europe Opioid Use Disorder Treatment Revenue by Country (2021-2026)
7.2 Europe Opioid Use Disorder Treatment Sales by Type (2021-2026)
7.3 Europe Opioid Use Disorder Treatment Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioid Use Disorder Treatment by Country
8.1.1 Middle East & Africa Opioid Use Disorder Treatment Sales by Country (2021-2026)
8.1.2 Middle East & Africa Opioid Use Disorder Treatment Revenue by Country (2021-2026)
8.2 Middle East & Africa Opioid Use Disorder Treatment Sales by Type (2021-2026)
8.3 Middle East & Africa Opioid Use Disorder Treatment Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioid Use Disorder Treatment
10.3 Manufacturing Process Analysis of Opioid Use Disorder Treatment
10.4 Industry Chain Structure of Opioid Use Disorder Treatment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioid Use Disorder Treatment Distributors
11.3 Opioid Use Disorder Treatment Customer
12 WORLD FORECAST REVIEW FOR OPIOID USE DISORDER TREATMENT BY GEOGRAPHIC REGION
12.1 Global Opioid Use Disorder Treatment Market Size Forecast by Region
12.1.1 Global Opioid Use Disorder Treatment Forecast by Region (2027-2032)
12.1.2 Global Opioid Use Disorder Treatment Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Opioid Use Disorder Treatment Forecast by Type (2027-2032)
12.7 Global Opioid Use Disorder Treatment Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Trevena
13.1.1 Trevena Company Information
13.1.2 Trevena Opioid Use Disorder Treatment Product Portfolios and Specifications
13.1.3 Trevena Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Trevena Main Business Overview
13.1.5 Trevena Latest Developments
13.2 Aphios
13.2.1 Aphios Company Information
13.2.2 Aphios Opioid Use Disorder Treatment Product Portfolios and Specifications
13.2.3 Aphios Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Aphios Main Business Overview
13.2.5 Aphios Latest Developments
13.3 Kyowa kirin
13.3.1 Kyowa kirin Company Information
13.3.2 Kyowa kirin Opioid Use Disorder Treatment Product Portfolios and Specifications
13.3.3 Kyowa kirin Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Kyowa kirin Main Business Overview
13.3.5 Kyowa kirin Latest Developments
13.4 Gamida-Cell
13.4.1 Gamida-Cell Company Information
13.4.2 Gamida-Cell Opioid Use Disorder Treatment Product Portfolios and Specifications
13.4.3 Gamida-Cell Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Gamida-Cell Main Business Overview
13.4.5 Gamida-Cell Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Opioid Use Disorder Treatment Product Portfolios and Specifications
13.5.3 Novartis Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Titan Pharmaceutical
13.6.1 Titan Pharmaceutical Company Information
13.6.2 Titan Pharmaceutical Opioid Use Disorder Treatment Product Portfolios and Specifications
13.6.3 Titan Pharmaceutical Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Titan Pharmaceutical Main Business Overview
13.6.5 Titan Pharmaceutical Latest Developments
13.7 Hikma Pharmaceutical
13.7.1 Hikma Pharmaceutical Company Information
13.7.2 Hikma Pharmaceutical Opioid Use Disorder Treatment Product Portfolios and Specifications
13.7.3 Hikma Pharmaceutical Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Hikma Pharmaceutical Main Business Overview
13.7.5 Hikma Pharmaceutical Latest Developments
13.8 MediciNova
13.8.1 MediciNova Company Information
13.8.2 MediciNova Opioid Use Disorder Treatment Product Portfolios and Specifications
13.8.3 MediciNova Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 MediciNova Main Business Overview
13.8.5 MediciNova Latest Developments
13.9 Alkermes
13.9.1 Alkermes Company Information
13.9.2 Alkermes Opioid Use Disorder Treatment Product Portfolios and Specifications
13.9.3 Alkermes Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Alkermes Main Business Overview
13.9.5 Alkermes Latest Developments
13.10 BioDelivery Sciences International
13.10.1 BioDelivery Sciences International Company Information
13.10.2 BioDelivery Sciences International Opioid Use Disorder Treatment Product Portfolios and Specifications
13.10.3 BioDelivery Sciences International Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 BioDelivery Sciences International Main Business Overview
13.10.5 BioDelivery Sciences International Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Opioid Use Disorder Treatment Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Opioid Use Disorder Treatment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Romiplostim
Table 4. Major Players of Omidubicel
Table 5. Major Players of Nalmefene
Table 6. Major Players of Others
Table 7. Global Opioid Use Disorder Treatment Sales by Type (2021-2026) & (K Units)
Table 8. Global Opioid Use Disorder Treatment Sales Market Share by Type (2021-2026)
Table 9. Global Opioid Use Disorder Treatment Revenue by Type (2021-2026) & ($ million)
Table 10. Global Opioid Use Disorder Treatment Revenue Market Share by Type (2021-2026)
Table 11. Global Opioid Use Disorder Treatment Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Opioid Use Disorder Treatment Sale by Application (2021-2026) & (K Units)
Table 13. Global Opioid Use Disorder Treatment Sale Market Share by Application (2021-2026)
Table 14. Global Opioid Use Disorder Treatment Revenue by Application (2021-2026) & ($ million)
Table 15. Global Opioid Use Disorder Treatment Revenue Market Share by Application (2021-2026)
Table 16. Global Opioid Use Disorder Treatment Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Opioid Use Disorder Treatment Sales by Company (2021-2026) & (K Units)
Table 18. Global Opioid Use Disorder Treatment Sales Market Share by Company (2021-2026)
Table 19. Global Opioid Use Disorder Treatment Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Opioid Use Disorder Treatment Revenue Market Share by Company (2021-2026)
Table 21. Global Opioid Use Disorder Treatment Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Opioid Use Disorder Treatment Producing Area Distribution and Sales Area
Table 23. Players Opioid Use Disorder Treatment Products Offered
Table 24. Opioid Use Disorder Treatment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Opioid Use Disorder Treatment Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Opioid Use Disorder Treatment Sales Market Share Geographic Region (2021-2026)
Table 29. Global Opioid Use Disorder Treatment Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Opioid Use Disorder Treatment Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Opioid Use Disorder Treatment Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Opioid Use Disorder Treatment Sales Market Share by Country/Region (2021-2026)
Table 33. Global Opioid Use Disorder Treatment Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Opioid Use Disorder Treatment Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Opioid Use Disorder Treatment Sales by Country (2021-2026) & (K Units)
Table 36. Americas Opioid Use Disorder Treatment Sales Market Share by Country (2021-2026)
Table 37. Americas Opioid Use Disorder Treatment Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Opioid Use Disorder Treatment Sales by Type (2021-2026) & (K Units)
Table 39. Americas Opioid Use Disorder Treatment Sales by Application (2021-2026) & (K Units)
Table 40. APAC Opioid Use Disorder Treatment Sales by Region (2021-2026) & (K Units)
Table 41. APAC Opioid Use Disorder Treatment Sales Market Share by Region (2021-2026)
Table 42. APAC Opioid Use Disorder Treatment Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Opioid Use Disorder Treatment Sales by Type (2021-2026) & (K Units)
Table 44. APAC Opioid Use Disorder Treatment Sales by Application (2021-2026) & (K Units)
Table 45. Europe Opioid Use Disorder Treatment Sales by Country (2021-2026) & (K Units)
Table 46. Europe Opioid Use Disorder Treatment Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Opioid Use Disorder Treatment Sales by Type (2021-2026) & (K Units)
Table 48. Europe Opioid Use Disorder Treatment Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Opioid Use Disorder Treatment Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Opioid Use Disorder Treatment Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Opioid Use Disorder Treatment Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Opioid Use Disorder Treatment Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Opioid Use Disorder Treatment
Table 54. Key Market Challenges & Risks of Opioid Use Disorder Treatment
Table 55. Key Industry Trends of Opioid Use Disorder Treatment
Table 56. Opioid Use Disorder Treatment Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Opioid Use Disorder Treatment Distributors List
Table 59. Opioid Use Disorder Treatment Customer List
Table 60. Global Opioid Use Disorder Treatment Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Opioid Use Disorder Treatment Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Opioid Use Disorder Treatment Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Opioid Use Disorder Treatment Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Opioid Use Disorder Treatment Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Opioid Use Disorder Treatment Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Opioid Use Disorder Treatment Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Opioid Use Disorder Treatment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Opioid Use Disorder Treatment Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Opioid Use Disorder Treatment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Opioid Use Disorder Treatment Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Opioid Use Disorder Treatment Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Opioid Use Disorder Treatment Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Opioid Use Disorder Treatment Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Trevena Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 75. Trevena Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 76. Trevena Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Trevena Main Business
Table 78. Trevena Latest Developments
Table 79. Aphios Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 80. Aphios Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 81. Aphios Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Aphios Main Business
Table 83. Aphios Latest Developments
Table 84. Kyowa kirin Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 85. Kyowa kirin Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 86. Kyowa kirin Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Kyowa kirin Main Business
Table 88. Kyowa kirin Latest Developments
Table 89. Gamida-Cell Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 90. Gamida-Cell Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 91. Gamida-Cell Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Gamida-Cell Main Business
Table 93. Gamida-Cell Latest Developments
Table 94. Novartis Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 95. Novartis Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 96. Novartis Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Novartis Main Business
Table 98. Novartis Latest Developments
Table 99. Titan Pharmaceutical Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 100. Titan Pharmaceutical Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 101. Titan Pharmaceutical Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Titan Pharmaceutical Main Business
Table 103. Titan Pharmaceutical Latest Developments
Table 104. Hikma Pharmaceutical Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 105. Hikma Pharmaceutical Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 106. Hikma Pharmaceutical Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Hikma Pharmaceutical Main Business
Table 108. Hikma Pharmaceutical Latest Developments
Table 109. MediciNova Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 110. MediciNova Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 111. MediciNova Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. MediciNova Main Business
Table 113. MediciNova Latest Developments
Table 114. Alkermes Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 115. Alkermes Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 116. Alkermes Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Alkermes Main Business
Table 118. Alkermes Latest Developments
Table 119. BioDelivery Sciences International Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 120. BioDelivery Sciences International Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 121. BioDelivery Sciences International Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. BioDelivery Sciences International Main Business
Table 123. BioDelivery Sciences International Latest Developments
Table 1. Opioid Use Disorder Treatment Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Opioid Use Disorder Treatment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Romiplostim
Table 4. Major Players of Omidubicel
Table 5. Major Players of Nalmefene
Table 6. Major Players of Others
Table 7. Global Opioid Use Disorder Treatment Sales by Type (2021-2026) & (K Units)
Table 8. Global Opioid Use Disorder Treatment Sales Market Share by Type (2021-2026)
Table 9. Global Opioid Use Disorder Treatment Revenue by Type (2021-2026) & ($ million)
Table 10. Global Opioid Use Disorder Treatment Revenue Market Share by Type (2021-2026)
Table 11. Global Opioid Use Disorder Treatment Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Opioid Use Disorder Treatment Sale by Application (2021-2026) & (K Units)
Table 13. Global Opioid Use Disorder Treatment Sale Market Share by Application (2021-2026)
Table 14. Global Opioid Use Disorder Treatment Revenue by Application (2021-2026) & ($ million)
Table 15. Global Opioid Use Disorder Treatment Revenue Market Share by Application (2021-2026)
Table 16. Global Opioid Use Disorder Treatment Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Opioid Use Disorder Treatment Sales by Company (2021-2026) & (K Units)
Table 18. Global Opioid Use Disorder Treatment Sales Market Share by Company (2021-2026)
Table 19. Global Opioid Use Disorder Treatment Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Opioid Use Disorder Treatment Revenue Market Share by Company (2021-2026)
Table 21. Global Opioid Use Disorder Treatment Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Opioid Use Disorder Treatment Producing Area Distribution and Sales Area
Table 23. Players Opioid Use Disorder Treatment Products Offered
Table 24. Opioid Use Disorder Treatment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Opioid Use Disorder Treatment Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Opioid Use Disorder Treatment Sales Market Share Geographic Region (2021-2026)
Table 29. Global Opioid Use Disorder Treatment Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Opioid Use Disorder Treatment Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Opioid Use Disorder Treatment Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Opioid Use Disorder Treatment Sales Market Share by Country/Region (2021-2026)
Table 33. Global Opioid Use Disorder Treatment Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Opioid Use Disorder Treatment Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Opioid Use Disorder Treatment Sales by Country (2021-2026) & (K Units)
Table 36. Americas Opioid Use Disorder Treatment Sales Market Share by Country (2021-2026)
Table 37. Americas Opioid Use Disorder Treatment Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Opioid Use Disorder Treatment Sales by Type (2021-2026) & (K Units)
Table 39. Americas Opioid Use Disorder Treatment Sales by Application (2021-2026) & (K Units)
Table 40. APAC Opioid Use Disorder Treatment Sales by Region (2021-2026) & (K Units)
Table 41. APAC Opioid Use Disorder Treatment Sales Market Share by Region (2021-2026)
Table 42. APAC Opioid Use Disorder Treatment Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Opioid Use Disorder Treatment Sales by Type (2021-2026) & (K Units)
Table 44. APAC Opioid Use Disorder Treatment Sales by Application (2021-2026) & (K Units)
Table 45. Europe Opioid Use Disorder Treatment Sales by Country (2021-2026) & (K Units)
Table 46. Europe Opioid Use Disorder Treatment Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Opioid Use Disorder Treatment Sales by Type (2021-2026) & (K Units)
Table 48. Europe Opioid Use Disorder Treatment Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Opioid Use Disorder Treatment Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Opioid Use Disorder Treatment Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Opioid Use Disorder Treatment Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Opioid Use Disorder Treatment Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Opioid Use Disorder Treatment
Table 54. Key Market Challenges & Risks of Opioid Use Disorder Treatment
Table 55. Key Industry Trends of Opioid Use Disorder Treatment
Table 56. Opioid Use Disorder Treatment Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Opioid Use Disorder Treatment Distributors List
Table 59. Opioid Use Disorder Treatment Customer List
Table 60. Global Opioid Use Disorder Treatment Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Opioid Use Disorder Treatment Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Opioid Use Disorder Treatment Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Opioid Use Disorder Treatment Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Opioid Use Disorder Treatment Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Opioid Use Disorder Treatment Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Opioid Use Disorder Treatment Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Opioid Use Disorder Treatment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Opioid Use Disorder Treatment Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Opioid Use Disorder Treatment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Opioid Use Disorder Treatment Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Opioid Use Disorder Treatment Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Opioid Use Disorder Treatment Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Opioid Use Disorder Treatment Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Trevena Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 75. Trevena Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 76. Trevena Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Trevena Main Business
Table 78. Trevena Latest Developments
Table 79. Aphios Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 80. Aphios Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 81. Aphios Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Aphios Main Business
Table 83. Aphios Latest Developments
Table 84. Kyowa kirin Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 85. Kyowa kirin Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 86. Kyowa kirin Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Kyowa kirin Main Business
Table 88. Kyowa kirin Latest Developments
Table 89. Gamida-Cell Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 90. Gamida-Cell Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 91. Gamida-Cell Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Gamida-Cell Main Business
Table 93. Gamida-Cell Latest Developments
Table 94. Novartis Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 95. Novartis Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 96. Novartis Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Novartis Main Business
Table 98. Novartis Latest Developments
Table 99. Titan Pharmaceutical Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 100. Titan Pharmaceutical Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 101. Titan Pharmaceutical Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Titan Pharmaceutical Main Business
Table 103. Titan Pharmaceutical Latest Developments
Table 104. Hikma Pharmaceutical Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 105. Hikma Pharmaceutical Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 106. Hikma Pharmaceutical Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Hikma Pharmaceutical Main Business
Table 108. Hikma Pharmaceutical Latest Developments
Table 109. MediciNova Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 110. MediciNova Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 111. MediciNova Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. MediciNova Main Business
Table 113. MediciNova Latest Developments
Table 114. Alkermes Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 115. Alkermes Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 116. Alkermes Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Alkermes Main Business
Table 118. Alkermes Latest Developments
Table 119. BioDelivery Sciences International Basic Information, Opioid Use Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 120. BioDelivery Sciences International Opioid Use Disorder Treatment Product Portfolios and Specifications
Table 121. BioDelivery Sciences International Opioid Use Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. BioDelivery Sciences International Main Business
Table 123. BioDelivery Sciences International Latest Developments
LIST OF FIGURES
Figure 1. Picture of Opioid Use Disorder Treatment
Figure 2. Opioid Use Disorder Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioid Use Disorder Treatment Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Opioid Use Disorder Treatment Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Opioid Use Disorder Treatment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Opioid Use Disorder Treatment Sales Market Share by Country/Region (2025)
Figure 10. Opioid Use Disorder Treatment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Romiplostim
Figure 12. Product Picture of Omidubicel
Figure 13. Product Picture of Nalmefene
Figure 14. Product Picture of Others
Figure 15. Global Opioid Use Disorder Treatment Sales Market Share by Type in 2026
Figure 16. Global Opioid Use Disorder Treatment Revenue Market Share by Type (2021-2026)
Figure 17. Opioid Use Disorder Treatment Consumed in Hospital
Figure 18. Global Opioid Use Disorder Treatment Market: Hospital (2021-2026) & (K Units)
Figure 19. Opioid Use Disorder Treatment Consumed in Drug Stores
Figure 20. Global Opioid Use Disorder Treatment Market: Drug Stores (2021-2026) & (K Units)
Figure 21. Opioid Use Disorder Treatment Consumed in Other
Figure 22. Global Opioid Use Disorder Treatment Market: Other (2021-2026) & (K Units)
Figure 23. Global Opioid Use Disorder Treatment Sale Market Share by Application (2025)
Figure 24. Global Opioid Use Disorder Treatment Revenue Market Share by Application in 2026
Figure 25. Opioid Use Disorder Treatment Sales by Company in 2026 (K Units)
Figure 26. Global Opioid Use Disorder Treatment Sales Market Share by Company in 2026
Figure 27. Opioid Use Disorder Treatment Revenue by Company in 2026 ($ millions)
Figure 28. Global Opioid Use Disorder Treatment Revenue Market Share by Company in 2026
Figure 29. Global Opioid Use Disorder Treatment Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Opioid Use Disorder Treatment Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Opioid Use Disorder Treatment Sales 2021-2026 (K Units)
Figure 32. Americas Opioid Use Disorder Treatment Revenue 2021-2026 ($ millions)
Figure 33. APAC Opioid Use Disorder Treatment Sales 2021-2026 (K Units)
Figure 34. APAC Opioid Use Disorder Treatment Revenue 2021-2026 ($ millions)
Figure 35. Europe Opioid Use Disorder Treatment Sales 2021-2026 (K Units)
Figure 36. Europe Opioid Use Disorder Treatment Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Opioid Use Disorder Treatment Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Opioid Use Disorder Treatment Revenue 2021-2026 ($ millions)
Figure 39. Americas Opioid Use Disorder Treatment Sales Market Share by Country in 2026
Figure 40. Americas Opioid Use Disorder Treatment Revenue Market Share by Country (2021-2026)
Figure 41. Americas Opioid Use Disorder Treatment Sales Market Share by Type (2021-2026)
Figure 42. Americas Opioid Use Disorder Treatment Sales Market Share by Application (2021-2026)
Figure 43. United States Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Opioid Use Disorder Treatment Sales Market Share by Region in 2026
Figure 48. APAC Opioid Use Disorder Treatment Revenue Market Share by Region (2021-2026)
Figure 49. APAC Opioid Use Disorder Treatment Sales Market Share by Type (2021-2026)
Figure 50. APAC Opioid Use Disorder Treatment Sales Market Share by Application (2021-2026)
Figure 51. China Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 55. India Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Opioid Use Disorder Treatment Sales Market Share by Country in 2026
Figure 59. Europe Opioid Use Disorder Treatment Revenue Market Share by Country (2021-2026)
Figure 60. Europe Opioid Use Disorder Treatment Sales Market Share by Type (2021-2026)
Figure 61. Europe Opioid Use Disorder Treatment Sales Market Share by Application (2021-2026)
Figure 62. Germany Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 63. France Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Opioid Use Disorder Treatment Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Opioid Use Disorder Treatment Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Opioid Use Disorder Treatment Sales Market Share by Application (2021-2026)
Figure 70. Egypt Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Opioid Use Disorder Treatment in 2026
Figure 76. Manufacturing Process Analysis of Opioid Use Disorder Treatment
Figure 77. Industry Chain Structure of Opioid Use Disorder Treatment
Figure 78. Channels of Distribution
Figure 79. Global Opioid Use Disorder Treatment Sales Market Forecast by Region (2027-2032)
Figure 80. Global Opioid Use Disorder Treatment Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Opioid Use Disorder Treatment Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Opioid Use Disorder Treatment Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Opioid Use Disorder Treatment Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Opioid Use Disorder Treatment Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Opioid Use Disorder Treatment
Figure 2. Opioid Use Disorder Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioid Use Disorder Treatment Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Opioid Use Disorder Treatment Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Opioid Use Disorder Treatment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Opioid Use Disorder Treatment Sales Market Share by Country/Region (2025)
Figure 10. Opioid Use Disorder Treatment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Romiplostim
Figure 12. Product Picture of Omidubicel
Figure 13. Product Picture of Nalmefene
Figure 14. Product Picture of Others
Figure 15. Global Opioid Use Disorder Treatment Sales Market Share by Type in 2026
Figure 16. Global Opioid Use Disorder Treatment Revenue Market Share by Type (2021-2026)
Figure 17. Opioid Use Disorder Treatment Consumed in Hospital
Figure 18. Global Opioid Use Disorder Treatment Market: Hospital (2021-2026) & (K Units)
Figure 19. Opioid Use Disorder Treatment Consumed in Drug Stores
Figure 20. Global Opioid Use Disorder Treatment Market: Drug Stores (2021-2026) & (K Units)
Figure 21. Opioid Use Disorder Treatment Consumed in Other
Figure 22. Global Opioid Use Disorder Treatment Market: Other (2021-2026) & (K Units)
Figure 23. Global Opioid Use Disorder Treatment Sale Market Share by Application (2025)
Figure 24. Global Opioid Use Disorder Treatment Revenue Market Share by Application in 2026
Figure 25. Opioid Use Disorder Treatment Sales by Company in 2026 (K Units)
Figure 26. Global Opioid Use Disorder Treatment Sales Market Share by Company in 2026
Figure 27. Opioid Use Disorder Treatment Revenue by Company in 2026 ($ millions)
Figure 28. Global Opioid Use Disorder Treatment Revenue Market Share by Company in 2026
Figure 29. Global Opioid Use Disorder Treatment Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Opioid Use Disorder Treatment Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Opioid Use Disorder Treatment Sales 2021-2026 (K Units)
Figure 32. Americas Opioid Use Disorder Treatment Revenue 2021-2026 ($ millions)
Figure 33. APAC Opioid Use Disorder Treatment Sales 2021-2026 (K Units)
Figure 34. APAC Opioid Use Disorder Treatment Revenue 2021-2026 ($ millions)
Figure 35. Europe Opioid Use Disorder Treatment Sales 2021-2026 (K Units)
Figure 36. Europe Opioid Use Disorder Treatment Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Opioid Use Disorder Treatment Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Opioid Use Disorder Treatment Revenue 2021-2026 ($ millions)
Figure 39. Americas Opioid Use Disorder Treatment Sales Market Share by Country in 2026
Figure 40. Americas Opioid Use Disorder Treatment Revenue Market Share by Country (2021-2026)
Figure 41. Americas Opioid Use Disorder Treatment Sales Market Share by Type (2021-2026)
Figure 42. Americas Opioid Use Disorder Treatment Sales Market Share by Application (2021-2026)
Figure 43. United States Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Opioid Use Disorder Treatment Sales Market Share by Region in 2026
Figure 48. APAC Opioid Use Disorder Treatment Revenue Market Share by Region (2021-2026)
Figure 49. APAC Opioid Use Disorder Treatment Sales Market Share by Type (2021-2026)
Figure 50. APAC Opioid Use Disorder Treatment Sales Market Share by Application (2021-2026)
Figure 51. China Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 55. India Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Opioid Use Disorder Treatment Sales Market Share by Country in 2026
Figure 59. Europe Opioid Use Disorder Treatment Revenue Market Share by Country (2021-2026)
Figure 60. Europe Opioid Use Disorder Treatment Sales Market Share by Type (2021-2026)
Figure 61. Europe Opioid Use Disorder Treatment Sales Market Share by Application (2021-2026)
Figure 62. Germany Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 63. France Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Opioid Use Disorder Treatment Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Opioid Use Disorder Treatment Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Opioid Use Disorder Treatment Sales Market Share by Application (2021-2026)
Figure 70. Egypt Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Opioid Use Disorder Treatment Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Opioid Use Disorder Treatment in 2026
Figure 76. Manufacturing Process Analysis of Opioid Use Disorder Treatment
Figure 77. Industry Chain Structure of Opioid Use Disorder Treatment
Figure 78. Channels of Distribution
Figure 79. Global Opioid Use Disorder Treatment Sales Market Forecast by Region (2027-2032)
Figure 80. Global Opioid Use Disorder Treatment Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Opioid Use Disorder Treatment Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Opioid Use Disorder Treatment Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Opioid Use Disorder Treatment Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Opioid Use Disorder Treatment Revenue Market Share Forecast by Application (2027-2032)
